Healthcare
Live Price
Offline$4.22
+4.20% today
1Y Change
+65.29%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
X4 Pharmaceuticals, Inc. (XFOR) is a Healthcare stock with a market cap of $50.00M and listed on NASDAQ. The stock last traded around $4.22 and up 65.3% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +1273.2%, EPS growth of +66.5%, a dividend yield of 0.0%. What stands out right now is revenue +1273.2%, EPS +66.5%, free cash flow +35.9% with operating margin -247.4% and ROIC -32.7%. Valuation is more restrained than many high-expectation growth names at price/sales 1.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines XFOR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
XFOR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
XFOR Max Drawdown
-41.32%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for XFOR and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.